For example, a fusion complex combining an IL-15 agonist coupled with a TGF-β molecular sink showed increased infiltration of both NK and CD8+ cytotoxic cells and lower tumor burden in a syngeneic mouse B16F10 melanoma model (125). This evidence concerns the gene IL15 and melanoma.